$0.8000
-0.0646-7.47%
Last update: Nov 10, 5:32 PM
TELA Bio Inc
TELANASDAQ
TELA Bio fell 27.3% from $1.19 to $0.86, behind the S&P 500's +9.8%. Its worst day was Mar 30 (−15.7%), and its low came Apr 13 at $0.56.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.19 beat the $-0.19 estimate on $20.7M revenue (est. $21.8M); FY revenue guidance of $80.4M against the $85.4M consensus.
−10.0% · S&P 500 0.0%
Story events cover the past 12 months · Times ET
EPS of $-0.17 beat the $-0.18 estimate on $20.9M revenue (est. $21.0M); FY revenue guidance of $86.7M against the $92.7M consensus.
−9.4% · S&P 500 +0.6%
TELA Bio closed at its lowest level of the year, 52.9% below where the year started.
−1.3% · S&P 500 +1.0%
TELA Bio shares rose 18.4%, while the S&P 500 rose 0.2%.
+18.4% · S&P 500 +0.2%
EPS of $-0.21 missed the $-0.18 estimate on $19.1M revenue (est. $18.9M); FY revenue guidance of $86.7M against the $86.9M consensus.
−5.9% · S&P 500 +0.6%
EPS of $-0.20 missed the $-0.18 estimate on $19.3M revenue (est. $20.0M).
−15.1% · S&P 500 −0.3%
TELA Bio closed at its highest level of the year, 18.5% above where the year started.
+8.5% · S&P 500 0.0%
Where it ended: a close of $0.86 on Nov 9, 2026.
Nothing in the past 12 months.
All TELA dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TELA and SPY from Benzinga historical bars. Not investment advice.
